A Pilot Study of Efficacy of Lactobacillus CD2 Lozenges in Preventing High-dose Chemotherapy Induced Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation
Interventional
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
incidence of grade III and grade IV mucositis
Determine the incidence of grade III and IV mucositis in patients undergoing allogeneic or autologous haematopoietic stem cell transplantation .
Day 24 of stem cell infusion or complete healing of mucositis
Yes
Atul Sharma, MD,DM
Principal Investigator
Dr BRA Institute Rotary Cancer Hospital ,All India Institute of Medical Sciences,New Delhi ,India.
India: Drugs Controller General of India
P1101
NCT01480011
November 2011
December 2012
Name | Location |
---|